Captor Therapeutics S.A. (CTX) — Cash Flow Reinvestment Rate
Captor Therapeutics S.A. (CTX) has a Cash Flow Reinvestment Rate of 1.94x as of March 2025, reinvesting zł44.69 Million (capex zł83.00K plus investments zł-44.60 Million) from operating cash flow of zł23.06 Million. See CTX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Captor Therapeutics S.A. Cash Flow Reinvestment Rate (2017–2019)
Historical reinvestment intensity for Captor Therapeutics S.A. across 2 annual periods. For the full cash flow conversion analysis, see Captor Therapeutics S.A. (CTX) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Captor Therapeutics S.A. (2017–2019)
Year-by-year capital reinvestment analysis for Captor Therapeutics S.A.. See Captor Therapeutics S.A. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.10x | zł460.00K | zł4.39 Million | zł229.00K | — |
| 2017 | 0.00x | zł0.00 | zł2.10 Million | zł0.00 | — |